The following uveitis papers, published in 2017, were selected by members of the American Uveitis Society for their outstanding teaching value for residents:
- Daniel E, Pistilli M, Kothari S, Khachatryan N, Kaçmaz RO, Gangaputra SS, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Nussenblatt RB, Rosenbaum JT, Levy-Clarke GA, Bhatt NP, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Research Group. Risk of ocular hypertension in adults with noninfectious uveitis. Ophthalmology 2017; 124: 1196-1208.
- De Parisot A, Kodjikian L, Errera MH, Sedira N, Heron E, Pérard L, Cornut PL, Schneider C, Rivière S, Ollé P, Pugnet G, Cathébras P, Manoli P, Bodaghi B, Saadoun D, Baillif S, Tieulie N, Andre M, Chiambaretta F, Bonin N, Bielefeld P, Bron A, Mouriaux F, Bienvenu B, Vicente S, Bin S, Broussolle C, Decullier E, Sève P; ULISSE group. Randomized controlled trial evaluating a standardized strategy for uveitis etiologic diagnosis (ULISSE). Am J Ophthalmol 2017; 178: 176-185.
- Durrani K, Kempen JH, Ying GS, Kacmaz RO, Artornsombudh P, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Foster CS; Systemic Immunosuppressive Therapy For Eye Diseases Site Research Group. Adalimumab for ocular inflammation. Ocul Immunol Inflamm 2017; 25: 405-412.
- Groen-Hakan F, Babu K, Tugal-Tutkun I, Pathanapithoon K, de Boer JH, Smith JR, de Groot-Mijnes JDF, Rothova A. Challenges of diagnosing viral anterior uveitis. Ocul Immunol Inflamm 2017; 25: 710-720.
- Ramanan AV, Dick AD, Jones AP, McKay A, Williamson PR, Compeyrot-Lacassagne S, Hardwick B, Hickey H, Hughes D, Woo P, Benton D, Edelsten C, Beresford MW; SYCAMORE Study Group. Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med 2017; 376: 1637-1646.
- Sen HN, Grange L, Akanda M, Fox A. Autoimmune retinopathy: Current concepts and practices (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc 2018; 115: T8
- Sepah YJ, Sadiq MA, Chu DS, Dacey M, Gallemore R, Dayani P, Hanout M, Hassan M, Afridi R, Agarwal A, Halim MS, Do DV, Nguyen QD. Primary (month-6) outcomes of the STOP-Uveitis study: Evaluating the safety, tolerability, and efficacy of tocilizumab in patients with noninfectious uveitis. Am J Ophthalmol 2017; 183: 71-80.
- Sève P, Cacoub P, Bodaghi B, Trad S, Sellam J, Bellocq D, Bielefeld P, Sène D, Kaplanski G, Monnet D, Brézin A, Weber M, Saadoun D, Chiquet C, Kodjikian L. Uveitis: Diagnostic work-up. A literature review and recommendations from an expert committee. Autoimmun Rev 2017; 16: 1254-1264.
- Sugar EA, Venugopal V, Thorne JE, Frick KD, Holland GN, Wang RC, Almanzor R, Jabs DA, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Longitudinal vision-related quality of life for patients with noninfectious uveitis treated with fluocinolone acetonide implant or systemic corticosteroid therapy. Ophthalmology 2017; 124: 1662-1669.
- Suhler EB, Thorne JE, Mittal M, Betts KA, Tari S, Camez A, Bao Y, Joshi A. Corticosteroid-related adverse events systematically increase with corticosteroid dose in noninfectious intermediate, posterior, or panuveitis: post hoc analyses from the VISUAL-1 and VISUAL-2 trials. Ophthalmology 2017; 124: 1799-1807.
- Writing Committee for the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group, Kempen JH, Altaweel MM, Holbrook JT, Sugar EA, Thorne JE, Jabs DA. Association between long-lasting intravitreous fluocinolone acetonide implant vs systemic anti-inflammatory therapy and visual acuity at 7 years among patients with intermediate, posterior, or panuveitis. JAMA 2017; 317: 1993-2005.
An American Uveitis Society Publication
Contributors:
Nisha Acharya, MD, MS; Levent Akduman, MD; Janet L. Davis, MD; James P. Dunn, MD; Albert Edwards, MD, PhD; José A. Flores-Guevara, MD; Sunir J. Garg, MD; Debra Goldstein, MD, FRCSC; Guy Jirawuthiworavong, MD, MA; Kashyap B. Kansupada, MD, FACS; Jared Knickelbein, MD, PhD; Laura
Kopplin, MD, PhD; Shree K. Kurup, MD; Kara C. LaMattina, MD; Kelly L. Larkin, MD; Paul Latkany, MD; Cecilia Lee, MD, MS; Joan Lee, DO; Shelly T. Lee, MD; Thellea Leveque, MD, MPH; Ralph D. Levinson, MD; Grace Levy-Clarke, MD; Phoebe Lin, MD, PhD; Todd Margolis, MD, PhD; Pauline T. Merrill, MD;
Virginia Miraldi Utz, MD; Ramana S. Moorthy, MD; Ghazala A.D. O’Keefe, MD; Armando Oliver, MD; Alan G. Palestine, MD; Sirichai Pasadhika, MD; Kathryn Pepple, MD, PhD; James Rosenbaum, MD; H. Nida Sen, MD, MHS; Jessica Shantha, MD; Mark Sherman, MD; Justine R. Smith, FRANZCO, PhD;
Lucia Sobrin, MD, MPH; Robert T. Swan, MD; Jennifer E. Thorne, MD, PhD; Albert T. Vitale, MD; Jonathan D. Walker, MD; Susan Wittenberg, MD; Ira G. Wong, MD; Steven Yeh, MD.
Acknowledgment:
The American Uveitis Society thanks Ms. Deb Sullivan for her administrative assistance in preparing this publication.